Circulating Biomarkers in Bladder Cancer
Bladder cancer is a molecularly heterogeneous disease characterized by multiple unmet needs in the realm of diagnosis, clinical staging, monitoring and therapy. There is an urgent need to develop precision medicine for advanced urothelial carcinoma. Given the difficulty of serial analyses of metasta...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
IOS Press
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181678/ |